Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Continued Access Study of Adefovir Dipivoxil for Patients With Chronic HBV Infection Who Have Completed a Gilead-Sponsored Study of Adefovir Dipivoxil.

NCT00158704 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT00158704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00158704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Continued Access Study of Adefovir Dipivoxil for Patients With Chronic HBV Infection Who Have Completed a Gilead-Sponsored Study of Adefovir Dipivoxil.
Lead sponsor
Gilead Sciences
Phase
Not applicable
Overall status
Terminated
Start date
January 31, 2002
Completion date
January 31, 2005
Enrollment
400
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b